Business / Finance

RSS

Butantan Institute signs collaboration agreement with MSD to develop dengue vaccines

On Wednesday, December 12, 2018, Brazil's Butantan Institute signed a collaboration agreement with Merck Sharp & Dohme (MSD) to develop dengue vaccines.

12 Dec 2018

New collaborative partnership in quest of novel antibiotics

The Global Antibiotic Research and Development Partnership, Eisai Co., Ltd. and Takeda Pharmaceutical Company Limited have signed an agreement for GARDP to access and screen components of Eisai and Takeda's chemical libraries.

12 Dec 2018

Subsidiaries of Community Health Systems sign definitive agreement to sell four South Carolina hospitals

Community Health Systems, Inc. announced today that subsidiaries of the Company have signed a definitive agreement to sell four South Carolina hospitals - 82-bed Chester Regional Medical Center in Chester, 225-bed Springs Memorial Hospital in Lancaster, 396-bed Carolinas Hospital System in Florence, and 124-bed Carolinas Hospital System - Marion in Mullins - along with related businesses, including physician clinic operations and outpatient services, to the Medical University Hospital Authority in Charleston, S.C.

20 Nov 2018

Nicoya designate the Institute for Stem Cell Biology and Regenerative Medicine as the OpenSPR Centre of Excellence

Currently in India, there are over 200,000 researchers working on numerous applications to better understand diseases and advance drug discovery. To support their discoveries, we are thrilled to announce the opening of the OpenSPR Centre of Excellence in Bangalore, India!

From Nicoya Lifesciences 15 Nov 2018

Empowering the NHS through Industry Partnerships

An interview with Cara Afzal and Lee-Ann Farrell discussing the importance of industry partnerships with the NHS, and how Janssen are working to improve dementia care for Manchester and hematology services for Wales.

13 Nov 2018

Illumina signs agreement to acquire Pacific Biosciences

Illumina, Inc. and Pacific Biosciences today announced they have signed an agreement for Illumina to acquire Pacific Biosciences at a price of $8.00 per Pacific Biosciences share in an all-cash transaction.

2 Nov 2018

RTI Surgical enters into definitive agreement to acquire Paradigm Spine

RTI Surgical, Inc., a global surgical implant company, and Paradigm Spine, LLC, a leader in motion preservation and non-fusion spinal implant technology, today announced that they have entered into a definitive agreement whereby RTI will acquire all outstanding equity interest of Paradigm Spine in a cash and stock transaction valued at up to $300 million, consisting of $150 million at closing plus potential future milestone payments.

2 Nov 2018

Reliable Respiratory announces acquisition of Attleboro Area Medical Equipment

Reliable Respiratory, one of New England's leading home respiratory and specialty medical equipment providers, today announced the acquisition of Attleboro Area Medical Equipment of Attleboro, Mass.

17 Oct 2018

Themis, Max-Planck-Innovation sign license agreement to develop and commercialize oncolytic virotherapies

Themis announced today that it has entered into a license agreement with Max-Planck-Innovation GmbH, the technology transfer agency of the Max Planck Society in Germany, granting it exclusive worldwide license to develop, manufacture and commercialize therapies based on an oncolytic measles virus platform that was jointly developed by the Eberhard-Karls-University Tübingen and the Max Planck Institute for Biochemistry. Financial terms of the agreement were not disclosed.

11 Oct 2018

Apollo Endosurgery to distribute cold Ensizor Flexible Endoscopic Scissors in select markets

Apollo Endosurgery, Inc., a global leader in less invasive medical devices for bariatric and gastrointestinal procedures, announced today that it has entered into an agreement with Slater Endoscopy, LLC to distribute the cold Ensizor® Flexible Endoscopic Scissors in the United States, Europe, and select other markets.

9 Oct 2018

Blackstone to acquire leading life sciences investment firm, Clarus

Blackstone today announced that it has agreed to acquire Clarus, a leading global life sciences investment firm that has raised $2.6 billion since its founding. Clarus, with offices in the life sciences hubs of Boston and San Francisco, is focused on funding growth-stage investments, often in partnership with major biopharmaceutical companies through R&D collaborations.

5 Oct 2018

Einstein Healthcare Network and Jefferson enter into binding Definitive Agreement

Einstein Healthcare Network and Jefferson (Philadelphia University + Thomas Jefferson University) have entered into a binding Definitive Agreement, legally binding the ideas and commitments described in the Letter of Intent, which the two organizations signed in March.

17 Sep 2018

Johnson & Johnson Medical acquires EIT to enhance interbody implant portfolio

Johnson & Johnson Medical Devices Companies, through its subsidiary Johnson & Johnson Medical GmbH, announced today the acquisition of Emerging Implant Technologies GmbH, a privately held manufacturer of 3D-printed titanium interbody implants for spinal fusion surgery, based in Wurmlingen, Germany.

From Johnson & Johnson 14 Sep 2018

Founder and Chairman of MR Solutions shortlisted for 2018 NatWest Great British Entrepreneur Awards

Founder and Chairman, Dr David Taylor, of Guildford based MR Solutions has been shortlisted as an Innovation Entrepreneur of the Year for London and the South East in the 2018 NatWest Great British Entrepreneur Awards.

From MR Solutions 7 Sep 2018

ITL Group announces completion of SMT manufacturing upgrade

Experienced medical device design, development, and manufacturing partner, ITL Group has announced further investment in its on-site PCB manufacturing facility.

From Vitl Life Science Solutions 24 Aug 2018

RDMD raises $3 million in seed funding to accelerate rare disease research, drug development

RDMD, a healthcare technology company dedicated to accelerating research for patients with rare diseases, today announced that it has raised $3 million in seed financing.

20 Aug 2018

OGT announces direct sales and support services in Europe

Oxford Gene Technology, The Molecular Genetics Company, has announced that it is now directly selling Cytocell Fluorescence In Situ Hybridisation products through several established affiliates of SysmexCorporation in Europe following its acquisition last year.

From Oxford Gene Technology 4 Jul 2018

CellGenix completes first phase of facility expansion to meet rising demands for GMP cell culture reagents

CellGenix, a global manufacturing leader of GMP-grade raw materials for cell therapy, gene therapy and tissue-engineered products, successfully completed the first phase of its headquarters’ expansion as more customers approach late-stage clinical development and commercialization.

22 Jun 2018

Siemens and Sartorius Stedim Biotech agree on long-term cooperation in the area of automation

The Siemens technology group and Sartorius Stedim Biotech (SSB), a leading international supplier for the biopharmaceutical industry, have agreed on long-term cooperation in the area of automation.

From Sartorius Lab Instruments GmbH & Co. KG 13 Jun 2018

Fluence Analytics announces distribution agreement with Nihon Rufuto in Japan

Fluence Analytics, a manufacturer of industrial and laboratory analytics products, today announced it has signed a distribution agreement with Nihon Rufuto, a Japanese company specializing in the import and domestic sales of scientific instruments.

From Yokogawa Fluence Analytics 7 Jun 2018